Conclusion
lumbar facet pain, pain, lumbar facet joint pain, FJI
LUMBAR FACET JOINT PAIN, REGRESSION
We report outcomes for the first pragmatic randomized trial comparing C-LRFA to FJI for treating lumbar facet pain in patients diagnosed with lumbar facet joint pain using the clinical criterion of ≥80% pain reduction in reponse to dual-comparative MBBs. In this study, C-LRFA demonstrated superior success rates compared to FJI across pain and functional outcome domains at the primary endpoint. In regression modeling, the odds of achieving ≥50% NPRS reduction for C-LRFA was more than 7 times the odds for FJI. This study reinforces the previous finding that lumbar radiofrequency ablation is an effective treatment for appropriately selected patients with lumbar facet joint pain.